Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma

Classical Hodgkin lymphoma (cHL) is a B-cell-derived lymphoid malignancy with the most favorable prognosis among various adult malignancies. However, once it becomes refractory disease to chemotherapy or relapses after high-dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT), it...

Descripción completa

Detalles Bibliográficos
Autores principales: Makita, Shinichi, Maruyama, Dai, Tobinai, Kensei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320890/
https://www.ncbi.nlm.nih.gov/pubmed/32606807
http://dx.doi.org/10.2147/OTT.S193951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7320890/
https://www.ncbi.nlm.nih.gov/pubmed/32606807
http://dx.doi.org/10.2147/OTT.S193951

Ejemplares similares